Insider · CIK 0001218821

THOMPSON VIRGIL

Reports to the SEC for 4 companies · EAST BRUNSWICK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001218821

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-27	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+23.6K sh	—	—	123,849
2023-06-27	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockM Exercise/Conversion	Director	MExercise/Conversion	−23.6K sh	—	—	0
2023-06-27	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockA Award	Director	AAward	+101K sh	—	—	101,365
2023-01-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockA Award	Director	AAward	+30K sh	—	—	30,000
2022-12-31	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.2K sh	—	—	100,213
2022-08-05	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,169 sh	—	—	16,693
2022-03-31	PCSAProcessa Pharmaceuticals, Inc.A Award	Director	AAward	+4,393 sh	—	—	16,693
2022-01-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockA Award	Director	AAward	+18.2K sh	—	—	19,377
2021-08-05	PCSAProcessa Pharmaceuticals, Inc.A Award	Director	AAward	+1,169 sh	—	—	12,300
2018-06-29	ARADIGM CORPStock Option (Right to Buy)A Award	Director	AAward	+97.3K sh	—	—	97,323
2017-06-01	ARADIGM CORPStock Option (Right to Buy)A Award	Director	AAward	+110K sh	—	—	110,485
2016-06-09	ARADIGM CORPStock Option (Right to Buy)A Award	Director	AAward	+35.9K sh	—	—	35,941
2015-11-12	ARADIGM CORPStock Option (Right to Buy)A Award	Director	AAward	+19.9K sh	—	—	19,940
2013-12-13	ARADIGM CORPS Sale	Director	SSale	−3,340 sh	$0.17	−$567.8	996,722
2013-12-13	ARADIGM CORPM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$0.16	+$1,600	1,006,722
2013-12-13	ARADIGM CORPStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	190,000
2013-12-04	SAVIENT PHARMACEUTICALS INCS Sale	Director	SSale	−107K sh	$0.02	−$2,455.273	0
2013-05-22	ARADIGM CORPA Award	Director	AAward	+333K sh	$0.15	+$50K	1,000,062
2013-05-22	ARADIGM CORPStock Option (Right to Buy)A Award	Director	AAward	+140K sh	—	—	140,000
2012-05-25	ARADIGM CORPA Award	Director	AAward	+167K sh	—	—	666,729
2012-05-25	ARADIGM CORPStock Option (right to buy)A Award	Director	AAward	+140K sh	—	—	140,000
2012-05-22	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+49.4K sh	$0.81	+$40K	109,575
2012-05-22	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $0.01 par valueA Award	Director	AAward	−69.7K sh	$0.81	−$56.5K	69,728
2011-06-22	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+192K sh	—	—	191,722
2011-05-26	ARADIGM CORPA Award	Director	AAward	+132K sh	—	—	500,062
2011-05-26	ARADIGM CORPStock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	547,500
2011-05-26	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+5,291 sh	$7.78	+$41.2K	60,193
2011-05-26	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $0.01 par valueA Award	Director	AAward	−7,031 sh	$7.78	−$54.7K	7,031
2010-09-23	SNGXSOLIGENIX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+300K sh	—	—	300,000
2010-09-02	SAVIENT PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$11.81	+$88.6K	54,902
2010-09-02	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $0.01 par valueM Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	$11.81	−$88.6K	0
2010-06-08	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	−3,514 sh	—	—	47,402
2010-06-08	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+3,514 sh	$11.38	+$40K	47,402
2010-06-08	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $0.01 par valueA Award	Director	AAward	−4,831 sh	$11.38	−$55K	4,831
2010-05-14	ARADIGM CORPA Award	Director	AAward	+208K sh	—	—	368,483
2010-05-14	ARADIGM CORPStock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2009-05-15	ARADIGM CORPA Award	Director	AAward	+156K sh	—	—	160,150
2009-05-15	ARADIGM CORPOption (Right to Buy)A Award	Director	AAward	+200K sh	—	—	200,000
2009-05-15	ARADIGM CORPA Award	Director	AAward	+156K sh	—	—	160,150
2009-05-05	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+7,448 sh	$5.37	+$40K	43,888
2009-05-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $0.01 par valueA Award	Director	AAward	+10.5K sh	$5.37	+$56.3K	10,486
2008-05-15	ARADIGM CORPOption (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2007-06-20	ARADIGM CORPOption (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2006-06-30	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+714 sh	$5.25	+$3,748.5	30,320
2006-06-30	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueA Award	Director	AAward	+5,000 sh	$5.25	+$26.3K	5,000
2006-06-30	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+714 sh	$5.25	+$3,748.5	30,320
2006-06-30	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueA Award	Director	AAward	+5,000 sh	$5.25	+$26.3K	5,000
2005-12-30	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+1,002 sh	$3.74	+$3,747.48	28,903
2005-12-30	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueA Award	Director	AAward	+5,000 sh	$3.74	+$18.7K	5,000
2005-09-30	SAVIENT PHARMACEUTICALS INCA Award	Director	AAward	+994 sh	$3.77	+$3,747.38	27,901

Recent filings

Accepted (ET)
Jul 244
THOMPSON VIRGIL0000897069-23-001002
SEC(opens sec.gov)
Jan 44
THOMPSON VIRGIL0001567619-23-000317
SEC(opens sec.gov)
Aug 94
THOMPSON VIRGIL0001567619-22-015300
SEC(opens sec.gov)
Apr 194
THOMPSON VIRGIL0001567619-22-008683
SEC(opens sec.gov)
Apr 44
THOMPSON VIRGIL0001567619-22-008008
SEC(opens sec.gov)
Aug 94
THOMPSON VIRGIL0001567619-21-014745
SEC(opens sec.gov)
Jul 34
THOMPSON VIRGIL0001123292-18-000850
SEC(opens sec.gov)
Jun 54
ARADIGM CORP0001123292-17-001081
SEC(opens sec.gov)
Jun 134
ARADIGM CORP0001123292-16-002395
SEC(opens sec.gov)
Nov 164
ARADIGM CORP0001209191-15-080229
SEC(opens sec.gov)
Dec 164
ARADIGM CORP0001209191-13-057169
SEC(opens sec.gov)
Dec 54
SAVIENT PHARMACEUTICALS INC0001181431-13-061539
SEC(opens sec.gov)
Jun 244
ARADIGM CORP0001209191-13-033341
SEC(opens sec.gov)
May 304
THOMPSON VIRGIL0001209191-12-031284
SEC(opens sec.gov)

Companies

Address

SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR

EAST BRUNSWICK, NJ, 08816